Picture of Epigenomics AG logo

ECX — Epigenomics AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Epigenomics Q3 EBITDA loss narrows to 2.0 million euros

Nov 15 (Reuters) - EPIGENOMICS AG  ECXn.DE : 
    * EPIGENOMICS AG ANNOUNCES 2017 THIRD QUARTER AND NINE 
MONTHS 
FINANCIAL RESULTS 
    * TOTAL Q3 2017 REVENUE DECREASED TO EUR 0.3 MILLION (Q3 
2016: 
EUR 0.9 MILLION) 
    * EBITDA IN Q3 2017 WAS AT EUR -2.0 MILLION (Q3 2016: EUR 
-2.5 
MILLION) 
    * NET LOSS PER SHARE FOR Q3 2017 DECREASED TO EUR -0.05 (Q3 
2016: 
EUR -0.11) 
    * REVENUE IS EXPECTED TO RANGE BETWEEN EUR 1.0 MILLION AND 
EUR 
1.5 MILLION IN FISCAL YEAR 2017. 
    * FY ADJUSTED EBITDA IS EXPECTED TO IMPROVE TO A RANGE 
BETWEEN 
EUR -10.5 MILLION AND EUR -11.5 MILLION 
 
Source text for Eikon:  ID:nEQ8HSj68a  
Further company coverage:  ECXn.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Epigenomics AG

See all news